Table 3.
Retinopathy (N vs. Y) | (101) 403 ± 221 | (83) 387 ± 168 | ns |
Nephropathy (N vs. Y) | (93) 414 ± 214 | (91) 363 ± 158 | t = 1.678, p < 0.1 |
PN (N vs. Y) | (125) 411 ± 211 | (59) 337 ± 148 | t = 2.431, p < 0.02 |
AN (N vs. Y) | (173) 389 ± 196 | (11) 321 ± 134 | ns |
MICRO (none vs. any) | (48) 433 ± 237 | (136) 383 ± 167 | ns |
| |||
IHD (N vs. Y) | (153) 392 ± 198 | (31) 367 ± 179 | ns |
CVD (N vs. Y) | (164) 392 ± 201 | (20) 353 ± 140 | ns |
PVD (N vs. Y) | (156) 397 ± 197 | (28) 333 ± 182 | t = 1.620, p < 0.15 |
MACRO (none vs. any) | (118) 404 ± 213 | (66) 359 ± 157 | t = 1.458, p < 0.15 |
| |||
HBP (N vs. Y) | (40) 455 ± 282 | (144) 370 ± 159 | t = 2.480, p < 0.02 |
Dyslipidemia (N vs. Y) | (84) 425 ± 201 | (100) 358 ± 185 | t = 2.363, p < 0.02 |